257
Cuervo AM. Calorie restriction and aging: the ultimate “cleansing diet.” J Gerontol A Biol Sci Med Sci. 2008;63(6):547–9. https://academic.oup.com/biomedgerontology/article/63/6/547/573952
258
Melnik BC. Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World J Diabetes. 2012;3(3):38. https://pubmed.ncbi.nlm.nih.gov/22442749/
259
Rittig N, Bach E, Thomsen HH, et al. Anabolic effects of leucine-rich whey protein, carbohydrate, and soy protein with and without ß-hydroxy-ß-methylbutyrate (Hmb) during fasting-induced catabolism: a human randomized crossover trial. Clin Nutr. 2017;36(3):697–705. https://pubmed.ncbi.nlm.nih.gov/27265181/
260
Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem. 2002;50:4998–5006. https://pubmed.ncbi.nlm.nih.gov/12166997/
261
Song D, Xu C, Holck AL, Liu R. Acrylamide inhibits autophagy, induces apoptosis and alters cellular metabolic profiles. Ecotoxicol Environ Saf. 2021;208:111543. https://pubmed.ncbi.nlm.nih.gov/33396091/
262
Huang M, Jiao J, Wang J, Chen X, Zhang Y. Associations of hemoglobin biomarker levels of acrylamide and all-cause and cardiovascular disease mortality among U.S. adults: National Health and Nutrition Examination Survey 2003–2006. Environ Pollut. 2018;238:852–8. https://pubmed.ncbi.nlm.nih.gov/29627755/
263
Naruszewicz M, Zapolska-Downar D, Kosmider A, et al. Chronic intake of potato chips in humans increases the production of reactive oxygen radicals by leukocytes and increases plasma C-reactive protein: a pilot study. Am J Clin Nutr. 2009;89(3):773–7. https://pubmed.ncbi.nlm.nih.gov/19158207/
264
Chase P, Mitchell K, Morley JE. In the steps of giants: the early geriatrics texts. J Am Geriatr Soc. 2000;48(1):89–94. https://pubmed.ncbi.nlm.nih.gov/10642028/
265
Madeo F, Zimmermann A, Maiuri MC, Kroemer G. Essential role for autophagy in life span extension. J Clin Invest. 2015;125(1):85–93. https://pubmed.ncbi.nlm.nih.gov/25654554/
266
Arnesen E, Huseby NE, Brenn T, Try K. The Tromsø Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest. 1986;46(1):63–70. https://pubmed.ncbi.nlm.nih.gov/2869572/
267
Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology. 2005;129(6):1928–36. https://pubmed.ncbi.nlm.nih.gov/16344061/
268
Hayat U, Siddiqui AA, Okut H, Afroz S, Tasleem S, Haris A. The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: a meta-analysis of 11 epidemiological studies. Ann Hepatol. 2021;20:100254. https://pubmed.ncbi.nlm.nih.gov/32920163/
269
Ray K. Caffeine is a potent stimulator of autophagy to reduce hepatic lipid content – a coffee for NAFLD? Nat Rev Gastroenterol Hepatol 2013;10:563. https://pubmed.ncbi.nlm.nih.gov/23982685/
270
Sinha RA, Farah BL, Singh BK, et al. Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology. 2014;59(4):1366–80. https://pubmed.ncbi.nlm.nih.gov/23929677/
271
Czachor J, Milek M, Galiniak S, Stepien K, Dzugan M, Molon M. Coffee extends yeast chronological lifespan through antioxidant properties. Int J Mol Sci. 2020;21(24):9510. https://pubmed.ncbi.nlm.nih.gov/33327536/
272
Sutphin GL, Bishop E, Yanos ME, Moller RM, Kaeberlein M. Caffeine extends life span, improves healthspan, and delays age-associated pathology in Caenorhabditis elegans. Longev Healthspan. 2012;1(1):9. https://pubmed.ncbi.nlm.nih.gov/24764514/
273
Pietrocola F, Malik SA, Mariño G, et al. Coffee induces autophagy in vivo. Cell Cycle. 2014;13(12):1987–94. https://pubmed.ncbi.nlm.nih.gov/24769862/
274
Takahashi K, Yanai S, Shimokado K, Ishigami A. Coffee consumption in aged mice increases energy production and decreases hepatic mTOR levels. Nutrition. 2017;38:1–8. https://pubmed.ncbi.nlm.nih.gov/28526373/
275
Известный слоган кофейного бренда Maxwell House. – Примеч. ред.
276
Saab S, Mallam D, Cox GA, Tong MJ. Impact of coffee on liver diseases: a systematic review. Liver Int. 2014;34(4):495–504. https://pubmed.ncbi.nlm.nih.gov/24102757/
277
Kanbay M, Siriopol D, Copur S, et al. Effect of coffee consumption on renal outcome: a systematic review and meta-analysis of clinical studies. J Ren Nutr. 2021;31(1):5–20. https://pubmed.ncbi.nlm.nih.gov/32958376/
278
Grosso G, Godos J, Galvano F, Giovannucci EL. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 2017;37:131–56. https://pubmed.ncbi.nlm.nih.gov/28826374/
279
Thomas DR, Hodges ID. Dietary research on coffee: improving adjustment for confounding. Curr Dev Nutr. 2020;4(nzz142). https://pubmed.ncbi.nlm.nih.gov/31938763/
280
Duregon E, Bernier M, de Cabo R. A glance back at the journal of gerontology – coffee, dietary interventions and life span. J Geront A Biol Sci Med Sci. 2020;75(11):2029–30. https://pubmed.ncbi.nlm.nih.gov/33057720/
281
Li Q, Liu Y, Sun X, et al. Caffeinated and decaffeinated coffee consumption and risk of all-cause mortality: a dose – response meta-analysis of cohort studies. J Hum Nut Diet. 2019;32(3):279–87. https://pubmed.ncbi.nlm.nih.gov/30786114/
282
Spiegelhalter D. Using speed of ageing and “microlives” to communicate the effects of lifetime habits and environment. BMJ. 2012 Dec 14;345:e8223. https://pubmed.ncbi.nlm.nih.gov/23247978/
283
Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024. https://pubmed.ncbi.nlm.nih.gov/29167102/
284
Loftfield E, Cornelis MC, Caporaso N, Yu K, Sinha R, Freedman N. Association of coffee drinking with mortality by genetic variation in caffeine metabolism: findings from the UK Biobank. JAMA Intern Med. 2018;178(8):1086. https://pubmed.ncbi.nlm.nih.gov/29971434/
285
Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J.